uniQure N.V. Nasdaq Global Select
Open: $18.99 High: $19.08 Low: $18.53 Close: $18.79
Range: 2022-06-27 - 2022-06-28
Market: Open
uniQure N.V. PAASHEUVELWEG 25A https://www.uniqure.com
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
  • CEO: Matthew C. Kapusta
  • Employees: 463
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
Latest news about the QURE